Why is Cell Point falling/rising?

As of 19-Nov, Cell Point (India) Ltd is experiencing a decline in its stock price, currently at 17.25, which reflects a decrease of 0.5 or 2.82%. The stock has underperformed its sector by 2.56% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the delivery volume has dropped significantly, with a 26.47% decrease compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has seen a return of -6.50%, and year-to-date, it has declined by 35.51%, which is substantially worse than the Sensex's positive return of 10.18% during the same period.
In the broader market context, while the Sensex has shown a slight increase of 0.68% over the past week and a notable gain of 10.18% year-to-date, Cell Point's performance starkly contrasts this trend, highlighting its struggles in the current market environment. The significant underperformance against the benchmark suggests that investor sentiment towards Cell Point is negative, likely influenced by the lack of positive factors and the recent decline in trading activity. Overall, the stock's persistent downward trajectory is compounded by weak investor interest and unfavorable comparisons to the broader market performance.